RECIST is crucial for ensuring uniformity and reproducibility in clinical trials. By providing a standardized framework, it allows for the comparison of results across different studies and aids in the regulatory approval process for new cancer treatments. This standardization helps in making informed decisions about the efficacy of new drugs and therapies.
